Trident Lifeline Limited (BOM:543616)

India flag India · Delayed Price · Currency is INR
279.00
+6.95 (2.55%)
At close: Feb 12, 2026
Market Cap3.33B -2.5%
Revenue (ttm)1.27B +111.5%
Net Income159.28M +57.7%
EPS13.78 +57.0%
Shares Out11.93M
PE Ratio20.25
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22,800
Average Volume11,100
Open263.00
Previous Close272.05
Day's Range263.00 - 285.00
52-Week Range222.00 - 328.00
Beta-0.26
RSI42.66
Earnings DateJan 17, 2026

About Trident Lifeline

Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target... [Read more]

Industry Pharmaceutical Preparations
Founded 2014
Employees 74
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543616
Full Company Profile

Financial Performance

In fiscal year 2025, Trident Lifeline's revenue was 869.65 million, an increase of 94.86% compared to the previous year's 446.29 million. Earnings were 117.48 million, an increase of 85.18%.

Financial Statements